Vaccinia | EPFL Graph Search

Êtes-vous un étudiant de l'EPFL à la recherche d'un projet de semestre?

Travaillez avec nous sur des projets en science des données et en visualisation, et déployez votre projet sous forme d'application sur GraphSearch.

Découvrez-en plus sur les applications Graph.

Vaccinia virus (VACV or VV) is a large, complex, enveloped virus belonging to the poxvirus family. It has a linear, double-stranded DNA genome approximately 190 kbp in length, which encodes approximately 250 genes. The dimensions of the virion are roughly 360 × 270 × 250 nm, with a mass of approximately 5–10 fg. The vaccinia virus is the source of the modern smallpox vaccine, which the World Health Organization (WHO) used to eradicate smallpox in a global vaccination campaign in 1958–1977. Although smallpox no longer exists in the wild, vaccinia virus is still studied widely by scientists as a tool for gene therapy and genetic engineering. Smallpox had been an endemic human disease that had a 30% fatality rate. In 1796, the British doctor Edward Jenner proved that an infection with the relatively mild cowpox virus would also confer immunity to the deadly smallpox. Jenner referred to cowpox as variolae vaccinae (smallpox of the cow). However, the origins of the smallpox vaccine became murky over time, especially after Louis Pasteur developed laboratory techniques for creating vaccines in the 19th century. Allan Watt Downie demonstrated in 1939 that the modern smallpox vaccine was serologically distinct from cowpox, and vaccinia was subsequently recognized as a separate viral species. Whole-genome sequencing has revealed that vaccinia is most closely related to horsepox, and the cowpox strains found in Great Britain are the least closely related to vaccinia. In addition to the morbidity of uncomplicated primary vaccination, transfer of infection to other sites by scratching, and post-vaccinial encephalitis, other complications of vaccinia infections may be divided into the following types: Generalized vaccinia Eczema vaccinatum Progressive vaccinia (vaccinia gangrenosum, vaccinia necrosum) Roseola vaccinia Vaccinia virus is closely related to the virus that causes cowpox; historically the two were often considered to be one and the same.

À propos de ce résultat

Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.

Publications associées (1)

Personnes associées (1)

Concepts associés (13)

Séances de cours associées (4)

Vaccinia

Variole du singe

La variole du singe, variole simienne, orthopoxvirose simienne, infection à virus monkeypox ou désormais « mpox » selon la terminologie adoptée le par l'Organisation mondiale de la santé (OMS), est une zoonose due à un virus de la famille des Poxviridae. Ce virus appartient au même genre Orthopoxvirus que celui de la variole humaine, maladie qui a été déclarée éradiquée par l'OMS depuis 1980. Elle est endémique principalement dans les forêts du centre de l'Afrique tropicale.

Variole

La variole ou petite vérole était une maladie infectieuse d'origine virale, très contagieuse et épidémique, due à un poxvirus. Le mot variole vient du latin (qui signifie « petite pustule », avec l'influence du mot , « varié, bigarré, tacheté, moucheté »). En effet, la variole se caractérise en quelque sorte par un « mouchetage de pustules ». La variole a été responsable jusqu'au de dizaines de milliers de morts par an rien qu'en Europe.

Vaccinia Virus Entry Is Followed by Core Activation and Proteasome-Mediated Release of the Immunomodulatory Effector VH1 from Lateral Bodies

Henning Paul-Julius Stahlberg, Lucia Reh

Host cell entry of vaccinia virus, the prototypic poxvirus, involves a membrane fusion event delivering the viral core and two proteinaceous lateral bodies (LBs) into the cytosol. Uncoating of viral cores is poorly characterized, and the composition and function of LBs remains enigmatic. We found that cytosolic cores rapidly dissociated from LBs and expanded in volume, which coincided with reduction of disulfide-bonded core proteins. We identified the abundant phosphoprotein F17, the dual-specificity phosphatase VH1, and the oxidoreductase G4 as bona fide LB components. After reaching the cytosol, F17 was degraded in a proteasome-dependent manner. Proteasome activity, and presumably LB disassembly, was required for the immediate immunomodulatory activity of VH1: dephosphorylation of STAT1 to prevent interferon-gamma-mediated antiviral responses. These results reveal a mechanism used by poxviruses to deliver viral enzymes to the host cell cytosol and are likely to facilitate the identification of additional LB-resident viral effectors.

Elsevier BV2013

Vaccination : de Jenner à l'immunisation moderne BIO-479: Immunology - advances and therapeutic implications

Explore l'histoire, l'impact et les défis de la vaccination, de Jenner à la vaccination moderne.

Tessellation: Analyse des données SMLM

Explore la tessellation pour l'analyse des données SMLM, couvrant les principes de segmentation et de colocalisation de Voronoi, les applications dans différents domaines, et l'intégration des méthodes de quantification.

Bases de la mécanique quantique CH-244: Quantum chemistry

Couvre les bases de la mécanique quantique, y compris l'élan angulaire et les niveaux d'énergie.